Your shopping cart is currently empty

Topoisomerase I (Compound ZML-14) inhibitor 3 induces HepG2 cell apoptosis and arrests cell cycle at G2/M phase. Topoisomerase I inhibitor 3 is an inhibitor of topoisomerase I that interact with topoisomerase I-DNA complex [1].

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | $1,520 | 6-8 weeks | 6-8 weeks | |
| 50 mg | $1,980 | 6-8 weeks | 6-8 weeks | |
| 100 mg | $2,500 | 6-8 weeks | 6-8 weeks |
| Description | Topoisomerase I (Compound ZML-14) inhibitor 3 induces HepG2 cell apoptosis and arrests cell cycle at G2/M phase. Topoisomerase I inhibitor 3 is an inhibitor of topoisomerase I that interact with topoisomerase I-DNA complex [1]. |
| In vitro | Topoisomerase I inhibitor 3 (Compound ZML-14) exhibits cytotoxic effects with IC50 values of 1.94 ± 0.09 μM for HepG2, 10.32 ± 0.39 μM for A2780, 13.1 ± 0.96 μM for HeLa, 40.69 ± 5.36 μM for HCT116, 28.11 ± 2.50 μM for SW1990, >100 μM for MCF7, and 37.42 ± 2.05 μM for L-02 cells, respectively [1]. |
| Molecular Weight | 311.31 |
| Formula | C18H14FNO3 |
| Cas No. | 2588211-50-9 |
| Smiles | FC=1C=C2C=3C(=NC=4C(C3)=CC(OC)=C(OC)C4)COC2=CC1 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.